Chemotherapy Dose Reductions and Dose Delays Due to Thrombocytopenia

被引：0
|
作者：
Prakash, Gautham [1 ]
Pandrangi, Kelsey [1 ]
Khateeb, Ranya [1 ]
Jain, Shivi [1 ]
机构：
[1] Rush Univ, Med Ctr, Chicago, IL USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-171193
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
311
引用
收藏
页码：11248 / 11249
页数：2
相关论文
共 50 条
  • [21] Nail dystrophy due to dose-intensive chemotherapy
    M. R. Weihrauch
    Michael S. von Bergwelt-Baildon
    International Journal of Hematology, 2009, 90 : 6 - 7
  • [22] THROMBOCYTOPENIA DUE TO PEFLOXACIN (PEFLACINE(R)) - DOSE-DEPENDENT TOXICITY
    CHICHMANIAN, RM
    SPREUX, A
    BERNARD, E
    GARRAFFO, R
    FUZIBET, JG
    THERAPIE, 1992, 47 (05): : 419 - 421
  • [23] Distraction delays a dose
    Lilley, LL
    Guanci, R
    AMERICAN JOURNAL OF NURSING, 1998, 98 (02) : 12 - 12
  • [24] Outcomes with enoxaparin dose reductions during thrombocytopenia in patients with hematopoietic stem cell transplantation (HSCT)
    Lam, Jenna
    Tavares, Erica
    Luk, Samantha O.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (06) : 1364 - 1370
  • [25] Impact of 10% Dose Reductions and Duration of Treatment Delays in the Management of Chemotherapy-Induced Neutropenia in Dogs Treated With Common Chemotherapy Protocols: A Single-Centre Experience
    Busser, Suzanne
    Blackwood, Laura
    Pereira, Constanza
    Chase-Topping, Margo
    Bavcar, Spela
    Fournier, Quentin
    VETERINARY AND COMPARATIVE ONCOLOGY, 2024, 22 (04) : 542 - 554
  • [26] The impact of dose delays and reductions on toxicity and progression free survival (PFS) in patients receiving palbociclib
    Clifton, Katherine K.
    Kimmel, Jaime
    Yi, Min
    Chad, Barnett
    Litton, Jennifer
    Debu, Tripathy
    Meghan, Karuturi
    CANCER RESEARCH, 2018, 78 (04)
  • [27] Factors associated with reductions in chemotherapy dose intensity: Impact of clinical, sociodemographic and practice setting
    Lyman, G. H.
    Kuderer, N. M.
    Poniewierski, M. S.
    Crawford, J.
    Wolff, D. A.
    Culakova, E.
    Dale, D. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] Impact of Dose Reductions, Delays Between Chemotherapy Cycles, and/or Shorter Courses of Adjuvant Chemotherapy in Stage II and III Colorectal Cancer Patients: a Single-Center Retrospective Study
    Sgouros J.
    Aravantinos G.
    Kouvatseas G.
    Rapti A.
    Stamoulis G.
    Bisvikis A.
    Res H.
    Samantas E.
    Journal of Gastrointestinal Cancer, 2015, 46 (4) : 343 - 349
  • [29] Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study
    Feliciano, Elizabeth M. Cespedes
    Lee, Valerie S.
    Prado, Carla M.
    Meyerhardt, Jeffrey A.
    Alexeeff, Stacey
    Kroenke, Candyce H.
    Xiao, Jingjie
    Castillo, Adrienne L.
    Caan, Bette J.
    CANCER, 2017, 123 (24) : 4868 - 4877
  • [30] Dose-dependent skeletal deficits due to varied reductions in mechanical loading in rats
    Ko, Frank C.
    Mortreux, Marie
    Riveros, Daniela
    Nagy, Janice A.
    Rutkove, Seward B.
    Bouxsein, Mary L.
    NPJ MICROGRAVITY, 2020, 6 (01)
12345